Axis Securities recommended stocks such as ICICI Bank, Maruti Suzuki India, State Bank of India, Dalmia Bharat, Federal Bank, Varun Beverages, Ashok Leyland, PNC Infra, ITC, Aarti Drugs, Gland Pharma, Mahindra CIE, Praj Industries, CCL Products (India), Polycab India and Bajaj finance.

‘Neither panic nor exuberance on Dalal Street’: Axis Securities recommends these 16 stocks to buy

Stocks to watch out for today: Tata Steel, RBL Bank, IDBI Bank, Kotak Mahindra Bank, SBI Card and more

Tata Steel, RBL Bank, SBI Card, Aarti Drugs among stocks to watch out for today

The company reported a 7 percent increase in revenue to Rs 743 crore compared to Rs 697 crore reported in the corresponding quarter of last fiscal while net profit increased marginally by 2 percent to Rs 56 crore.

Aarti Drugs trades 5% higher on steady March quarter earnings

12 out of the 15 sector gauges -- compiled by the National Stock Exchange -- were trading in the green. Sub-indexes Nifty Financial Services, Nifty PSU Bank and Nifty Metal were outperforming the NSE platform by rising as much as 1 per cent, 1.39 per cent and 0.51 per cent, respectively.

Sensex rises over 200 points as RBI keeps repo rate unchanged, Nifty tops 17,600; Cholamandalam Investment, Aarti Drugs jump up to 8%

Aarti Drugs, Anupam Rasayan and ITI bucked the trend to outperform during the week

Stocks that shone in the week ended March 24

Aarti Drugs share price today: The stock has recovered 30.21% from 52 week low of Rs 310.80 hit on March 20, 2023 . The stock hit a 52 week high of Rs 531.60 on April 7, 2022.

Aarti Drugs shares zoom 30% from 52-week low; here’s the new target price

Aarti Drugs shares zoom 8% intraday; recover 30% from 52-week low

ITI Ltd, Cyient Ltd, Great Eastern Shipping Company Ltd and Minda Corporation Ltd are among the other gainers in the BSE’s ‘A’ group today, 24 March 2023.

Aarti Drugs Ltd leads gainers in ‘A’ group

Aarti Drugs Ltd witnessed volume of 98415 shares by 10:47 IST on BSE, a 3.34 times surge over two-week average daily volume of 29431 shares

Volumes jump at Aarti Drugs Ltd counter

Aarti Drugs share price: The counter’s 14-day relative strength index (RSI) came at 53.56. A level below 30 is defined as oversold while a value above 70 is considered overbought. The company’s stock has a price-to-equity (P/E) ratio of 19.23.

Aarti Drugs shares recover sharply from one-year low, jump 16%; here’s what tech charts hint

Aarti Drugs Ltd recorded volume of 20.32 lakh shares by 14:14 IST on NSE, a 16.83 times surge over two-week average daily volume of 1.21 lakh shares

Volumes soar at Aarti Drugs Ltd counter

Price return has been average, nothing exciting

Performance

Seems to be overvalued vs the market average

Valuation

Lagging behind the market in financials growth

Growth

Showing good signs of profitability & efficiency

Profitability

The stock is underpriced and is not in the overbought zone

Current price is less than the intrinsic value

Fundamentals

Good time to consider, stock is not in the overbought zone

Technicals

Entry point

Promoter pledged holding

Unsolicited messages

Default probability

Red flags

Aarti Drugs Limited is a pharmaceutical company  offering active pharmaceutical ingredients (APIs) in a range of therapeutic categories, such as anti-inflammatory, cardioprotectant, antifungals, antibiotic, antidiabetic, sedative and vitamins.

Aarti Drugs Ltd